Chiroscience Chirocaine Labeling Cites Possible Safety Advantage
Executive Summary
Approved labeling for Chiroscience's long-acting local anesthetic Chirocaine (levobupivacaine) indicates a possible cardiac and central nervous system safety advantage over bupivacaine based on animal data.